pBItetDMPKSGFP Citations (1)
Originally described in: RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1.Lee JE, Bennett CF, Cooper TA Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4221-6. doi: 10.1073/pnas.1117019109. Epub 2012 Feb 27. PubMed Journal
Articles Citing pBItetDMPKSGFP
| Articles |
|---|
| Repurposing pentamidine using hyaluronic acid-based nanocarriers for skeletal muscle treatment in myotonic dystrophy. Repellin M, Carton F, Boschi F, Galie M, Perduca M, Calderan L, Jacquier A, Carras J, Schaeffer L, Briancon S, Lollo G, Malatesta M. Nanomedicine. 2023 Jan;47:102623. doi: 10.1016/j.nano.2022.102623. Epub 2022 Oct 26. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.